Edwards Urges Full Fed. Circ. To Limit FDA Safe Harbor
By Dani Kass · May 28, 2024, 4:22 PM EDT
Edwards Lifesciences has petitioned the full Federal Circuit to narrow its interpretation of a U.S. Food and Drug Administration safe harbor that essentially allows patent infringement during drug development, arguing that...
To view the full article, register now.